Volinanserin

Volinanserin
Clinical data
Other names	MDL-100,907; M100907
ATC code	None;
Identifiers
	IUPAC name (R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]-4-piperidyl]methanol;
CAS Number	139290-65-6;
PubChem CID	5311271;
IUPHAR/BPS	185;
ChemSpider	4470782;
UNII	EW71EE171J;
ChEMBL	ChEMBL74355;
CompTox Dashboard (EPA)	DTXSID6047363 ;
ECHA InfoCard	100.123.797
Chemical and physical data
Formula	C22H28FNO3
Molar mass	373.468 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c3cc(F)ccc3CCN(CC2)CCC2C(O)c(c1OC)cccc1OC;

Volinanserin (INN; developmental code MDL-100,907) is a highly selective 5-HT_2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT_2A receptor. It was also tested in clinical trials as a potential antipsychotic, antidepressant, and treatment for insomnia but was never marketed.